Fort Collins’ Colorado State University researchers in the Department of Psychology are launching a three-staged research project using the GoFire Health Suite made by GoFire and designed to evaluate the effectiveness of GoFire’s data-gathering technology for cannabis research, as well as the efficiency of the GoFire Inhaler’s medicine delivery process.
Stage I of the research, currently underway by lead researcher Bradley T. Conner, PhD, associate professor and director of addiction counseling at Colorado State University and his colleague, Mark A. Prince, PhD, will include 20 participants utilizing the GoFire inhaler and GoFire App to measure and track cannabis intake and outcomes with a goal of validating the technology as a research measurement tool.
In Stage II, 15 participants will utilize the GoFire Inhaler and App to determine how automatic, real-time data collection can inform health outcomes associated with cannabis. The second stage will also include a pharmacokinetic study to measure the bioavailability provided by the delivery mechanism of the GoFire Inhaler. A third stage will combine results from the first two stages to enable large-scale clinical trials aimed at determining the association between cannabis use and health outcomes.
What is GoFire Health Suite?
It includes the IoT-enabled inhaler with proprietary SMART cartridges and the GoFire App with DoseCode technology. The GoFire inhaler creates the first truly precise, microdose-enabled and medical-grade mechanism for the use of plant-based medicines. The GoFire App creates an environment for consumers and physicians to find plant-based medicines that work with specific human ailments, while also enabling true tracking and monitoring of the effectiveness of products through GoFire DoseCodes and SMART cartridges. The GoFire Inhaler works in conjunction with the GoFire App, connecting via Bluetooth to automate the collection of real-time data and eliminating the current practice of self-reporting. The vendor claims that working together, the GoFire Inhaler and the App create the world’s most expensive, data-rich IoT environment for the study of cannabis medicines.